Search Results - "Brunet Mas, Eduard"
-
1
Selecting the Best Combined Biological Therapy for Refractory Inflammatory Bowel Disease Patients
Published in Journal of clinical medicine (18-02-2022)“…Current medical treatment for inflammatory bowel disease (IBD) does not achieve 100% response rates, and a subset of refractory and severely ill patients have…”
Get full text
Journal Article -
2
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Published in Alimentary pharmacology & therapeutics (01-09-2024)“…Summary Background Ulcerative proctitis (UP) can have a milder, less aggressive course than left‐sided colitis or extensive colitis. Therefore,…”
Get full text
Journal Article -
3
Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry
Published in Journal of Crohn's and colitis (05-09-2024)“…Abstract Background and Aims Switching from intravenous infliximab (IV-IFX) to subcutaneous biosimilar infliximab (SC-IFX) has been shown to safely maintain…”
Get full text
Journal Article -
4
Economic impact of inflammatory bowel disease in Catalonia: a population-based analysis
Published in Therapeutic advances in gastroenterology (01-01-2024)“…Inflammatory bowel disease (IBD) has a major economic impact on healthcare costs. The aim of this study was to evaluate the current healthcare expenditure…”
Get full text
Journal Article -
5
Ischemic colitis due to Kayexalate crystals
Published in Gastroenterología y Hepatología (English Edition) (01-04-2024)Get full text
Journal Article -
6
Cyclosporine treatment for severe steroid refractory immune-mediated colitis in a patient with ulcerative colitis
Published in Gastroenterología y Hepatología (English Edition) (01-01-2024)Get full text
Journal Article -
7
EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE AMONG EARLY-INDUSTRIALIZED REGIONS OF THE WORLD: CHALLENGES IN SUSTAINABLE HEALTHCARE DELIVERY
Published in Inflammatory bowel diseases (25-01-2024)“…Abstract BACKGROUND Early-industrialized regions (e.g., North America, Europe, Oceania) are currently in stage 3 of the epidemiologic evolution of inflammatory…”
Get full text
Journal Article -
8
-
9
Migratory intestinal stenosis by primary intestinal amyloidosis. A case report
Published in Gastroenterología y hepatología (01-03-2023)Get more information
Journal Article -
10
929 IMPACT OF TELEMONITORING ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE IN SPAIN: A MULTICENTER TECCU CLINICAL TRIAL
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2023)Get full text
Journal Article -
11
Migratory intestinal stenosis by primary intestinal amyloidosis. A case report
Published in Gastroenterología y Hepatología (English Edition) (01-03-2023)Get full text
Journal Article -
12
MACHINE LEARNING CLASSIFICATION OF THE EPIDEMIOLOGIC STAGES OF INFLAMMATORY BOWEL DISEASE ACROSS GEOGRAPHY AND TIME
Published in Gastroenterology (New York, N.Y. 1943) (01-02-2024)Get full text
Journal Article -
13
MODELING THE TRANSITION TO THE FOURTH EPIDEMIOLOGIC STAGE OF INFLAMMATORY BOWEL DISEASE: PREVALENCE EQUILIBRIUM
Published in Gastroenterology (New York, N.Y. 1943) (01-02-2024)Get full text
Journal Article -
14
-
15
MODELING THE TRANSITION TO THE FOURTH EPIDEMIOLOGIC STAGE OF INFLAMMATORY BOWEL DISEASE: PREVALENCE EQUILIBRIUM
Published in Inflammatory bowel diseases (25-01-2024)“…Abstract BACKGROUND A theoretical framework for population-level transition across four epidemiologic stages has been proposed for inflammatory bowel disease…”
Get full text
Journal Article -
16
TRENDS IN INFLAMMATORY BOWEL DISEASE INCIDENCE AND PREVALENCE ACROSS EPIDEMIOLOGIC STAGES: A GLOBAL SYSTEMATIC REVIEW WITH META-ANALYSIS
Published in Inflammatory bowel diseases (25-01-2024)“…Abstract BACKGROUND Rising incidence and prevalence of inflammatory bowel disease (IBD) observed historically in early-industrialized regions now also appear…”
Get full text
Journal Article -
17
MACHINE LEARNING CLASSIFICATION OF THE EPIDEMIOLOGIC STAGES OF INFLAMMATORY BOWEL DISEASE ACROSS GEOGRAPHY AND TIME
Published in Inflammatory bowel diseases (25-01-2024)“…Abstract BACKGROUND Epidemiologic stages of inflammatory bowel disease (IBD) have been proposed: 1. Emergence (low incidence and prevalence); 2. Acceleration…”
Get full text
Journal Article -
18
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
Published in Digestive and liver disease (01-11-2024)“…The efficacy of ustekinumab and vedolizumab for treating complex perianal fistula in Crohn's disease has been barely studied. We aimed to assess treatment…”
Get full text
Journal Article -
19
Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital
Published in Journal of clinical medicine (01-10-2023)“…Background and objectives: Thiopurines are an effective treatment for the maintenance of remission in inflammatory bowel disease (IBD). They can present…”
Get full text
Journal Article -
20
Subcutaneous infliximab cut-off points in patients with inflammatory bowel disease. Data from the ENEIDA registry
Published in Journal of Crohn's and colitis (22-08-2024)“…Switching from the intravenous to the subcutaneous biosimilar infliximab (SC-IFX) has been shown to safely maintain clinical remission and increase drug levels…”
Get full text
Journal Article